Target Name: ZNF805
NCBI ID: G390980
Other Name(s): Zinc finger protein 805 | ZN805_HUMAN | zinc finger protein 805 | CTC-444N24.8 | Zinc finger protein 805, transcript variant 1 | Zinc finger protein 805 (isoform 1) | ZNF805 variant 1

ZNF805: A Potential Drug Target and Biomarker for Chronic Pain

Introduction

Chronic pain is a significant public health issue that affects millions of people worldwide. The World Health Organization (WHO) estimates that chronic pain costs the global economy approximately 632 billion dollars per year. Chronic pain can be caused by various conditions, including fibromyalgia, diabetes , cancer, and neurodegenerative diseases. These conditions can be debilitating and often result in significant quality of life loss.

ZNF805: A Potential Drug Target and Biomarker

The Zinc Finger Protein 805 (ZNF805) gene is a promising drug target and biomarker for the treatment of chronic pain. ZNF805 is a non-coding RNA molecule that plays a role in the regulation of various cellular processes, including pain signaling. It is a key regulator of the pain transduction pathway, which is involved in the transmission of pain signals from the body to the central nervous system (CNS).

The ZNF805 gene has been shown to be involved in the regulation of pain signaling pathways, including the transduction pathway, neuromuscular junction, neuroendocrine junction and prostaglandin synthesis. ZNF805 has been shown to play a role in the regulation of pain perception, chronic pain expression, and neuroinflammation.

Potential Therapeutic Applications

The potential therapeutic applications of ZNF805 are vast and include the treatment of chronic pain conditions such as fibromyalgia, osteoarthritis, and neurodegenerative diseases. ZNF805 has also been shown to have potential therapeutic applications in the treatment of other conditions, including cancer and neuroinflammation.

In the Treatment of Fibromyalgia

Fibromyalgia is a chronic pain condition that is characterized by widespread pain and stiffness. The prevalence of fibromyalgia is estimated to be approximately 17% of the general population, with a higher incidence in women. Fibromyalgia can be a debilitating condition that significantly affects quality of life.

Recent studies have shown that ZNF805 is involved in the regulation of pain signaling pathways in fibromyalgia. ZNF805 has been shown to play a role in the regulation of pain perception, neuroinflammation, and the modulation of pain modalities. Therefore, ZNF805 may be a promising therapeutic target for the treatment of fibromyalgia.

In the Treatment of Osteoarthritis

Osteoarthritis is a common condition that affects the joints, causing pain, stiffness, and reduced range of motion. The prevalence of osteoarthritis is estimated to be approximately 27% of the population, with a higher incidence in older adults. Osteoarthritis can be a debilitating condition that significantly affects quality of life.

Recent studies have shown that ZNF805 is involved in the regulation of pain signaling pathways in osteoarthritis. ZNF805 has been shown to play a role in the regulation of pain perception, neuroinflammation, and the modulation of pain modalities. Therefore, ZNF805 may be a promising therapeutic target for the treatment of osteoarthritis.

In the Treatment of Neurodegenerative Diseases

Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are progressive neurological conditions that are characterized by the progressive loss of brain cells. These conditions can be debilitating and have a significant impact on quality of life.

Recent studies have shown that ZNF805 is involved in the regulation of pain signaling pathways in neurodegenerative diseases. ZNF805 has been shown to play a role in the regulation of pain perception, neuroinflammation, and the modulation of pain modalities. Therefore, ZNF805 may be a promising therapeutic target for the treatment of neurodegenerative diseases.

Potential Biomarkers

ZNF805 may also be

Protein Name: Zinc Finger Protein 805

Functions: May be involved in transcriptional regulation

More Common Targets

ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A | ZNG1B | ZNG1C | ZNG1E | ZNG1F | ZNHIT1 | ZNHIT2 | ZNHIT3 | ZNHIT6 | ZNRD2 | ZNRD2-DT | ZNRF1 | ZNRF2 | ZNRF2P1 | ZNRF3 | ZNRF3-AS1 | ZNRF4 | ZP1 | ZP2 | ZP3 | ZP4 | ZPBP | ZPBP2 | ZPLD1 | ZPLD2P | ZPR1 | ZRANB1 | ZRANB2 | ZRANB2-AS1 | ZRANB2-DT | ZRANB3 | ZRS | ZRSR2 | ZRSR2P1 | ZSCAN1 | ZSCAN10 | ZSCAN12 | ZSCAN12P1 | ZSCAN16 | ZSCAN16-AS1 | ZSCAN18 | ZSCAN2 | ZSCAN20 | ZSCAN21